Diagnostics

Artificial Intelligence Point-of-Care Testing Software Solutions Cancer Care Imaging Solutions Blood Testing Blood Analysis Biosciences Molecular Testing Blood Tests Imaging Devices Cancer Detection Healthcare Infrastructure Cancer Testing Patient Monitoring Research and Development Life Sciences Tools Siemens Healthineers Capillary Testing Radiology AI in Medicine

3 ARTICLES

4mo ago

FDA Clears Tempus xT CDx to Run as Tumor‑Only Diagnostic

The approval removes the matched‑normal requirement so clinicians can test tumor tissue alone and opens a path for Tempus to migrate its DNA solid‑tumor tests into FDA‑cleared assays under ADLT pricing.

6 ARTICLES

4mo ago

Roche to Acquire PathAI for $750 Million Upfront Plus Up to $300 Million in Milestones

11 ARTICLES

9mo ago

Minot Light’s Q3 Letter Posts 7.6% Gain, Trails Micro‑Cap Benchmark, Highlights Arq, Lucid and Stran

5 ARTICLES

last yr.

Waters to Acquire BD’s Biosciences and Diagnostics Business Through $17.5 Billion Reverse Morris Trust